Atari: A forgotten shell, a legacy brand, and 1bn of valuable tax losses

(Full access for Lifetime Members only)

Image: JR Moreira / Shutterstock.com

Exclusive report for Lifetime Members only

Exclusive report for Lifetime Members only

Atari: A forgotten shell, a legacy brand, and 1bn of valuable tax losses

30 November 2022

What readers said about this report

When someone on the inside of a company is keen to buy every single share that they can possibly get hold of, it's usually a sign that you should pay attention.

That's the situation right now at Atari SA, the Euronext/Paris listed company that owns one of the most iconic and – potentially – most valuable brands of the early days of computing and gaming.

Admittedly, you have to be a bit of a Sherlock Holmes to investigate this opportunity. However, that's also the point. If things were already clearer than they are, you would have already seen chat forums, blogs and other investment publications latch onto the situation.

To the best of my knowledge, no one else has spelled out this story yet.

All I will reveal in public is this:

  • Atari doesn't just have the brand name, but also a staggering EUR 1bn in tax loss carryforwards (enabling nearly EUR 200m in saved taxes).
  • Its major shareholder has been buying additional stock hand over fist.
  • The company has pledged not to delist or squeeze out shareholders, but to remain a public company under its new major shareholder.

This is a very unusual special situation. Atari has a low market cap of EUR 73m, but 71% of its shares are currently in free float. Stock does change hands, but it's an investment for experienced investors only.

This opportunity is exclusively available to Undervalued-Shares.com Lifetime Members.

Not a Lifetime Member yet? Sign up for a Membership - just USD 999/one-off.
Already a Lifetime Member? Log into your account to download the report.

|  What readers said about this report

Sandeep G.
November 2022

I read your article about Atari. Very interesting take.

Most recent

Sark – it’s not a big deal

Sark – it’s not a big deal

I had mobilised GBP 30m to buy a portfolio of real estate in Sark, with plans to IPO the company. How did it go, and what may happen next?

read more

Latest reports (for Members only)

2-2.5x from an investment holding liquidation

2-2.5x from an investment holding liquidation

This AIM-listed small-cap will likely return all its capital to shareholders. Underresearched by investors, it's an opportunity that shouldn't even exist – but it does.

Ukraine reconstruction: one stock to benefit

Ukraine reconstruction: one stock to benefit

If or when the war in Ukraine ends, this stock will likely become the focus of investor money pushing into the country.

Actinium-225, aka "the world's rarest drug"

Actinium-225, aka "the world's rarest drug"

This little-known Western European company could become the global market leader for supplying the uber-rare "Ac-225", a potent weapon to treat cancer.